Financial Avengers’s Takeda Pharmaceutical TAK Stock Holding History

Financial Avengers’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46.3K	Hold	2,500	–	–	0.02%	63
2025 Q4	$39K	Hold	2,500	–	–	0.02%	69
2025 Q3	$36.6K	Sell	2,500 -855	-25%	-$12.7K	0.02%	72
2025 Q2	$51.9K	Sell	3,355 -645	-16%	-$9.53K	0.02%	61
2025 Q1	$59.5K	Sell	4,000 -2,211	-36%	-$31K	0.03%	57
2024 Q4	$82.2K	Hold	6,211	–	–	0.04%	50
2024 Q3	$88.3K	Buy	6,211 +3,355	+117%	+$47.6K	0.04%	51
2024 Q2	$37K	Hold	2,856	–	–	0.02%	68
2024 Q1	$39K	Hold	2,856	–	–	0.02%	67
2023 Q4	$40.8K	Hold	2,856	–	–	0.02%	63
2023 Q3	$44.2K	Buy	+2,856	New	+$44.2K	0.03%	60

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Financial Avengers's TAK Position: Q1 2026 in Review

Financial Avengers held its Takeda Pharmaceutical (TAK) position steady in Q1 2026 at 2,500 shares worth $46.3K. The position accounts for 0.02% of the portfolio, ranked #63.

Financial Avengers first reported a position in TAK in Q3 2023 and has held it in 11 quarters since. The position peaked at $88.3K in Q3 2024. 359 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Financial Avengers held 2,500 shares of Takeda Pharmaceutical worth $46.3K as of Q1 2026.
Financial Avengers left its Takeda Pharmaceutical share count unchanged in Q1 2026.
Takeda Pharmaceutical made up 0.02% of Financial Avengers's portfolio in Q1 2026, its #63 holding.
Financial Avengers first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 11 quarters since.
Financial Avengers's Takeda Pharmaceutical position peaked at $88.3K in Q3 2024.
359 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Financial Avengers's 13F filing for Q1 2026, filed 19 May 2026.